205171-06-8 Usage
Uses
Used in Cardiovascular Applications:
N-Cyclopentyl-2'-C-methyl-adenosine is used as a therapeutic agent for the cardiovascular system, potentially offering benefits in the treatment and management of cardiovascular diseases. Its effects on the cardiovascular system are under investigation, with the aim of identifying its specific contributions to heart health.
Used in Anti-Inflammatory and Immunosuppressive Applications:
In the medical field, N-Cyclopentyl-2'-C-methyl-adenosine is utilized as an anti-inflammatory and immunosuppressive agent. Its potential in this area is being explored for the management of conditions characterized by inflammation and immune system overactivity, offering a new avenue for treatment options.
Used in Neurological Disorder Treatment:
N-Cyclopentyl-2'-C-methyl-adenosine is used as a modulator of adenosine receptor activity, which has implications for the treatment of certain neurological disorders. N-Cyclopentyl-2'-C-methyl-adenosine's interaction with adenosine receptors could provide therapeutic benefits in neurological conditions where adenosine signaling is implicated, thus offering a novel approach to treatment.
Used in Pharmaceutical Development:
In the pharmaceutical industry, N-Cyclopentyl-2'-C-methyl-adenosine is used as a lead compound in drug development. Its unique structure and potential medicinal properties make it a valuable candidate for further research and development into new drugs targeting a range of diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 205171-06-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,1,7 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 205171-06:
(8*2)+(7*0)+(6*5)+(5*1)+(4*7)+(3*1)+(2*0)+(1*6)=88
88 % 10 = 8
So 205171-06-8 is a valid CAS Registry Number.
205171-06-8Relevant academic research and scientific papers
N6-cycloalkyl- And n6-bicycloalkyl-c5'(c 2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice
Franchetti, Palmarisa,Cappellacci, Loredana,Vita, Patrizia,Petrelli, Riccardo,Lavecchia, Antonio,Kachler, Sonja,Klotz,Marabese, Ida,Luongo, Livio,Maione, Sabatino,Grifantini, Mario
scheme or table, p. 2393 - 2406 (2010/04/30)
To further investigate new potent and selective human A1 adenosine receptor agonists, we have synthesized a series of 5'-chloro-5'-deoxy- and 5'-(2-fluorophenylthio)-5'-deoxy-N6-cycloalkyl(bicycloalkyl)- substituted adenosine and 2'-C-methylade
NUCLEOSIDE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION
-
Page/Page column 113, (2010/02/07)
Disclosed are compounds, compositions and methods for treating hepatitis C virus infections.
2'-C-Methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies
Franchetti, Palmarisa,Cappellacci, Loredana,Marchetti, Stefano,Trincavelli, Letizia,Martini, Claudia,Mazzoni, Maria R.,Lucacchini, Antonio,Grifantini, Mario
, p. 1708 - 1715 (2007/10/03)
2'-C-Methyl analogues of selective adenosine receptor agonists such as (R)-PIA, CPA, CCPA, NECA, and IB-MECA were synthesized in order to further investigate the subdomain that binds the ribose moiety. Binding affinities of these new compounds at A1
